November 30th has finally passed, and as we expected Watson Pharmaceuticals has finally released its long-awaited generic version of Pfizer’s blockbuster cholesterol drug, Lipitor. Watson’s generic version of Lipitor is the first to hit the U.S. market. We’ know there’s a lot of hoopla going on out there with generic Lipitor right now, so here’s the low-down on what we know:
According to a Watson spokesman, Watson has shipped about 1.5 million bottles of their generic version of Lipitor, and shipped the generic Lipitor to 28,000 pharmacies. Some have already received shipments of generic Lipitor and have made it available to patients.
Watson Watson Chief Executive Paul Bisaro has already told CNBC that the company is selling its generic version of Lipitor at a 50% discount the recent prices for brand name Lipitor. Recently listed prices for Lipitor have ranged from $3.50 to $5 per pill, depending on the region of the country, so even though it doesn’t look like Lipitor prices will drop to rock-bottom yet, we’re still hoping that cholesterol patients will still see a big cut in their pharmaceutical bills.
Ranbaxy Laboratories was also expected to release a generic version of Lipitor, that seems to be on hold for the moment. In the last few years, the FDA had cited Ranbaxy for manufacturing deficiencies at plants in India, and has accused Ranbaxy of providing falsified data and test results in drug applications to the agency.
Have you been waiting for generic Lipitor to be released? Tell us about it!
- Generic Drug News: Ranbaxy Still Plans to Sell Generic Lipitor in November
- Generic Lipitor To Finally Arrive, But When Will Prices Drop?
- Generic Lipitor Is Due Out Next Month, But Will Prices Come Down Anytime Soon?
- Generic Lipitor Is Coming, But Will Prices Come Down?
- Generic Lipitor Release Halted in the UK Until May 2012